secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001193125-25-258692
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus reports preliminary Q3 cash position of $104M as of Sep 30, 2025
-----------------------------------------------------------------------

- Expected cash, cash equivalents, and investments of approximately $104.0 million.
- Includes $27.0 million in cash and cash equivalents.
- Figures are preliminary, subject to final closing procedures.
- No update on sales under Jefferies ATM agreement after September 30.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000119312525258692/0001193125-25-258692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000119312525258692/crbp-20251030.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-258692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer